國家衛生研究院 NHRI:Item 3990099045/1428
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907918      Online Users : 890
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/1428


    Title: No association of GRIP1 gene polymorphisms with schizophrenia in Chinese population
    Authors: Tsai, SJ;Liou, YJ;Liao, DL;Cheng, CY;Hong, CJ
    Contributors: Division of Mental Health and Substance Abuse Research
    Abstract: Disturbance in glutamate neurotransmission has been implicated in the pathophysiology of schizophrenia. Since glutamate receptor interacting protein 1 (GRIP 1), a modular protein that enables anchoring of AMPA receptors via its PDZ (postsynaptic density-95/discs large/zona occludens-1) domain and modulates D-serine release, plays an important role in glutamatergic function, this study tests the hypothesis that GRIP1 genetic variants confer susceptibility to schizophrenia. This study investigated whether GRIP1 genetic polymorphisms (rs1038923 and rs4913301) cause a predisposal to schizophrenia. Two GRIP1 polymorphisms were studied in a sample population of 252 people with schizophrenia and 207 normal controls. Significant linkage disequilibrium was obtained between the two polymorphisms. Results demonstrated that neither single marker nor haplotype analysis revealed an association between variants at the GRIP1 locus and schizophrenia, suggesting that it is unlikely that the GRIP1 polymorphisms investigated play a substantial role in conferring susceptibility to schizophrenia. However, association between schizophrenia and other polymorphisms in the GRIPI gene cannot be totally ruled out as the whole gene was not covered by the two polymorphisms studied. (c) 2007 Elsevier Inc. All rights reserved.
    Keywords: Clinical Neurology;Neurosciences;Pharmacology & Pharmacy;Psychiatry
    Date: 2007-04-13
    Relation: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007 Apr;31(3):752-755.
    Link to: http://dx.doi.org/10.1016/j.pnpbp.2007.01.015
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0278-5846&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000246166100025
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33947494899
    Appears in Collections:[Ding-Lieh Liao(2005-2008)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000246166100025.pdf132KbAdobe PDF1032View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback